**Background**
Cyclooxygenase-1 (COX-1) is a constitutive enzyme that plays a critical role in the synthesis of prostaglandins, which are involved in maintaining gastric mucosa, renal blood flow, and platelet aggregation. Dysregulation of the COX pathway is often linked to inflammatory responses and the progression of various malignancies. Furthermore, oxidative stress and inflammation in the central nervous system are key drivers of neuronal cytotoxicity and cognitive deficits, such as episodic memory loss. Identifying compounds that can modulate these pathways is essential for developing therapeutic strategies for inflammatory diseases and neurodegenerative conditions. In this context, we will introduce a natural flavonoid with potent biological properties – Catechin.
**Definition**
Catechin ((+)-Catechin) is a polyphenol and flavanol that acts as an inhibitor of cyclooxygenase-1 (COX-1) with an IC50 value of 1.4 μM.
**In Vitro and In Vivo Studies**
The Catechin biological activity has been extensively studied across various cell lines and animal models. In vitro, Catechin exhibits >95% inhibitory activity against COX-1 at a concentration of 70 μg/mL. In MCF-7 cells, treatment with Catechin leads to a dose- and time-dependent induction of apoptosis; specifically, 40.7% and 41.16% of cells undergo apoptosis after 24 hours of treatment with 150 μg/mL and 300 μg/mL, respectively. Furthermore, treatment with 150 μg/mL Catechin for 24 hours increases the expression levels of p53, Caspase-3, -8, and -9 by 2.68, 5.81, 1.42, and 3.29 fold, respectively. Regarding Catechin cancer research, the compound has shown cytotoxicity against various human cell lines, including A2780, A549, and BGC-823, typically with IC50 values > 10 μg/mL. Additionally, it demonstrates anti-inflammatory effects in BV-2 cells, inhibiting LPS-induced NO production with IC50 values ranging from 9.52 μM to 26.11 μM.
Catechin in vivo studies have highlighted its neuroprotective potential. In Wistar rats, administration of Catechin (200 mg/kg, p.o.) effectively prevents time-induced episodic memory deficits in a dose-dependent manner. Moreover, treatment with Catechin prevents the rise of myeloperoxidase (MPO) levels in the hippocampus (21.98±9.44%) and frontal cortex (36.76±4.39%) compared to groups treated with doxorubicin alone. In conclusion, Catechin is a versatile flavonoid that inhibits COX-1 and exerts potent anti-apoptotic and neuroprotective effects.
Keywords
Catechin, 154-23-4, (+)-Catechin, Cianidanol, Catechuic acid, COX, Apoptosis, Influenza Virus, Endogenous Metabolite, Cyclooxygenase, Inhibitor, inhibitor, inhibit
References
[1] Waffo-Téguo P, et al. Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr Cancer. 2001;40(2):173-9.
[2] Alshatwi AA. Catechin hydrate suppresses MCF-7 proliferation through TP53/Caspase-mediated apoptosis. J Exp Clin Cancer Res. 2010 Dec 17;29:167.
[3] Cheruku SP, et al. Catechin ameliorates doxorubicin-induced neuronal cytotoxicity in in vitro and episodic memory deficit in in vivo in Wistar rats. Cytotechnology. 2018 Feb;70(1):245-259.